Genesco (NYSE:GCO - Get Free Report) announced its earnings results on Thursday. The company reported ($1.14) earnings per share for the quarter, topping analysts' consensus estimates of ($1.25) by $0.11, Zacks reports. Genesco had a negative net margin of 0.67% and a positive return on equity of 2.22%. During the same period in the prior year, the firm earned ($0.83) earnings per share. The business's revenue was up 4.0% on a year-over-year basis. Genesco updated its FY 2026 guidance to 1.300-1.700 EPS.
Genesco Price Performance
Shares of GCO opened at $32.87 on Thursday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.55 and a current ratio of 1.91. The stock has a 50 day simple moving average of $24.15 and a 200 day simple moving average of $24.30. Genesco has a 52-week low of $16.19 and a 52-week high of $44.80. The firm has a market capitalization of $354.30 million, a PE ratio of -21.07 and a beta of 2.25.
Analyst Ratings Changes
Several brokerages have weighed in on GCO. Truist Financial boosted their price objective on Genesco from $23.00 to $25.00 and gave the stock a "hold" rating in a report on Thursday, June 5th. Wall Street Zen cut Genesco from a "buy" rating to a "hold" rating in a report on Friday, May 30th. Seaport Res Ptn raised Genesco from a "hold" rating to a "strong-buy" rating in a research note on Tuesday. Finally, Jefferies Financial Group reaffirmed a "hold" rating and issued a $24.00 price target (down from $27.00) on shares of Genesco in a research note on Wednesday, May 21st. One analyst has rated the stock with a Strong Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $24.50.
Check Out Our Latest Report on GCO
Insider Activity
In related news, major shareholder Fund 1 Investments, Llc sold 25,000 shares of the business's stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $23.26, for a total value of $581,500.00. Following the completion of the transaction, the insider directly owned 1,072,850 shares in the company, valued at approximately $24,954,491. The trade was a 2.28% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 23.11% of the company's stock.
Hedge Funds Weigh In On Genesco
Several institutional investors and hedge funds have recently modified their holdings of GCO. Jones Financial Companies Lllp acquired a new position in shares of Genesco in the 1st quarter valued at approximately $26,000. Tower Research Capital LLC TRC grew its position in shares of Genesco by 37.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 5,514 shares of the company's stock valued at $109,000 after purchasing an additional 1,499 shares during the period. Cetera Investment Advisers acquired a new position in shares of Genesco in the 2nd quarter valued at approximately $208,000. Engineers Gate Manager LP acquired a new position in shares of Genesco in the 2nd quarter valued at approximately $264,000. Finally, Quantinno Capital Management LP acquired a new position in Genesco during the 2nd quarter worth approximately $310,000. 94.51% of the stock is currently owned by institutional investors and hedge funds.
About Genesco
(
Get Free Report)
Genesco Inc operates as a retailer and wholesaler of footwear, apparel, and accessories in the United States, Puerto Rico, Canada, the United Kingdom, and the Republic of Ireland. The company operates through four segments: Journeys Group, Schuh Group, Johnston & Murphy Group, and Genesco Brands.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genesco, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genesco wasn't on the list.
While Genesco currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.